FDA to remove 'black box' warnings on some menopause hormone therapies
CBS America · Just In
CBS America
Just In
The Food and Drug Administration says it is removing safety warnings for many hormone therapy drugs prescribed to ease symptoms of menopause and perimenopause.
Breakdown
- The FDA will remove black box safety warnings from many hormone therapies for menopause and perimenopause.
- Previous warnings cited increased risks of breast cancer, dementia, heart attack, and strokes. 15s
- FDA officials state the original study supporting the warnings was flawed and not supported by later clinical trials. 25s
- Experts say hormone therapy may reduce risks of cognitive decline, heart attacks, bone fractures, and other conditions. 31s
- The removal of warnings is expected to increase access to hormone therapy and improve patient outcomes if accompanied by updated medical training. 3m 3s